Dimethyl fumarate–induced lymphopenia in MS due to differential T-cell subset apoptosis

Abstract excerpt

OBJECTIVE: T-cell lymphopenia induced by dimethyl fumarate (DMF) treatment of MS. METHODS: Total lymphocyte counts and comprehensive T-cell subset analyses were performed in high-quality samples obtained from patients with MS prior to and serially following DMF treatment initiation. Random coefficient mixed-effects analysis was used to model the trajectory of T-cell subset losses in vivo. Survival and apoptosis...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Immune Response and Inflammation
• Share to Multiple Sclerosis Research Studies
• Share to T-cell and B-cell Immunology